CHEST-CA: Study of Chest Pain and Hidden Cardiac Amyloidosis
Condition(s) studied
Investigational drug(s) / intervention(s)
Screening thourgh examinations including bonescintigraphy: Clinical examination, blood samples, echo, bone scintigraphy
Study summary
The objective of this observational, prospective study is to determine the prevalence of Cardiac Amyloidosis (CA) in males over the age of 65 who experience chest pain but show no signs of coronary artery disease (CAD).
Prior to inclusion, all patients will have undergone a CT coronary angiogram or an Rb-PET scan to rule out the possibility of CAD.
Participants will be subject to several examinations, including blood tests, urine samples, ECG, echocardiography, and bone scintigraphy. An endomyocardial biopsy may be conducted if necessary.
Eligibility
Primary outcome measure(s)
- Prevalence of ATTR-CA in patients experiencing chest pain — Up to 4 weeks
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Rigshospitalet | Copenhagen | Denmark | Recruiting |
More Copenhagen University Hospital, Rigshospitalet trials in Denmark
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07435168 on ClinicalTrials.gov ↗ ← All trials in Denmark